Cargando…

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study

BK virus-associated nephropathy (PvAN) increases the risk of graft failure justifying treatment. Conversion to mammalian target of rapamycin inhibitors (mTORi) and Human polyclonal immunoglobulins (IVIg) could prevent the risk of PvAN. Our retrospective study assessed the efficacy of mTORi associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vela, Carla, Jouve, Thomas, Chevallier, Eloi, Imerzoukene, Farida, Germi, Raphaële, Le Marechal, Marion, Truffot, Aurélie, Fiard, Gaëlle, Janbon, Bénédicte, Giovannini, Diane, Malvezzi, Paolo, Rostaing, Lionel, Noble, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785214/ https://www.ncbi.nlm.nih.gov/pubmed/36555909 http://dx.doi.org/10.3390/jcm11247292

Ejemplares similares

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021)

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring
por: Noble, Johan, et al.
Publicado: (2021)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

Immortal Time-Bias–Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients
por: Noble, Johan, et al.
Publicado: (2021)

Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?
por: Malvezzi, Paolo, et al.
Publicado: (2018)

Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review
por: Cabezas, Lara, et al.
Publicado: (2022)

Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports
por: Laamech, Reda, et al.
Publicado: (2022)

Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant Survival
por: Terrec, Florian, et al.
Publicado: (2021)

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study
por: Jouve, Thomas, et al.
Publicado: (2023)

Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response
por: Terrec, Florian, et al.
Publicado: (2021)

Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
por: Terrec, Florian, et al.
Publicado: (2019)

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)

Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study
por: Jouve, Thomas, et al.
Publicado: (2022)

SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy
por: Truffot, Aurélie, et al.
Publicado: (2021)

Virological Markers in Epstein–Barr Virus-Associated Diseases
por: Lupo, Julien, et al.
Publicado: (2023)

Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2020)

Tocilizumab and Desensitization in Kidney Transplant Candidates: Personal Experience and Literature Review
por: Weinhard, Jules, et al.
Publicado: (2021)

Pretransplant BKV-IgG serostatus and BKV-specific ELISPOT assays to predict BKV infection after kidney transplantation
por: Bae, Hyunjoo, et al.
Publicado: (2023)

Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage
por: Malvezzi, Paolo, et al.
Publicado: (2015)

Costimulation Blockade in Kidney Transplantation: An Update
por: Malvezzi, Paolo, et al.
Publicado: (2016)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
por: Naciri Bennani, Hamza, et al.
Publicado: (2019)

Kidney Transplantation for Focal Segmental Glomerulosclerosis: Can We Prevent Its Recurrence? Personal Experience and Literature Review
por: Naciri Bennani, Hamza, et al.
Publicado: (2021)

Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results
por: Lupo, Julien, et al.
Publicado: (2022)

Cryoglobulinemia and double‐filtration plasmapheresis: Personal experience and literature review
por: Naciri Bennani, Hamza, et al.
Publicado: (2022)

BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients
por: Stervbo, Ulrik, et al.
Publicado: (2019)

The effect of BKV reactivation on cytokines behavior in kidney transplanted patients
por: Rahimi, Zahra, et al.
Publicado: (2022)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

Stepwise Reduction of Mycophenolate Mofetil with Conversion to Everolimus for the Treatment of Active BKV in Kidney Transplant Recipients: A Single-Center Experience in Vietnam
por: Kien, Truong Quy, et al.
Publicado: (2022)

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2016)

No detection of EBV, BKV and JCV in breast cancer tissue samples in Iran
por: Dowran, Razieh, et al.
Publicado: (2019)

Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
por: Bertrand, Dominique, et al.
Publicado: (2020)

An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient
por: Manière, Louis, et al.
Publicado: (2019)

Steroid-Based Therapy and Risk of Infectious Complications
por: Rostaing, Lionel, et al.
Publicado: (2016)

The association between polyomavirus BK strains and BKV viruria in liver transplant recipients
por: Wang, Robert Y. L., et al.
Publicado: (2016)

Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence
por: An, Ping, et al.
Publicado: (2019)

Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation
por: Salamonowicz-Bodzioch, Małgorzata, et al.
Publicado: (2021)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

1544. Kinetics of BK Virus in Urine Associated with BKV DNAemia and BKVAN in Pediatric Kidney Transplantation
por: Yamada, Masaki, et al.
Publicado: (2018)

Polyclonal gammopathy after BKV infection in HSCT recipient: a novel trigger for plasma cells replication?
por: Maximova, Natalia, et al.
Publicado: (2015)

Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case–control study
por: Gras, Julien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4dshpa2iqngta25afr0hklll1j